The association between LOC126806658 (BRD4-Independent Group 4 Enhancer GRCh37_chr3:41265899-41267098) and Ovarian Cancer is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources1
Clinical variants4
Symptoms8
Compounds0
Trials0
Publications1
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.